In an effort to move fast toward treatments and potential therapies, PALS has partnered with four of the world’s leading mitochondrial disease patient advocacy groups to form and fund an international Leigh Syndrome Research Network.
Viva la Vida! was overwhelming success.
To better reflect its international reach, the Leigh Syndrome Registry has been renamed.
NIH is seeking patients for a natural history study of Leigh syndrome and its relationship to infection.